Highly regarded DOJ attorney Mark Hamer has joined Baker & McKenzie’s Global Antitrust and Competition Practice as a Partner in Washington, DC, bringing more than 25 years of extensive antitrust litigation experience, both as a senior trial lawyer with the government and as an antitrust litigator in private practice.
Mr. Hamer was with the DOJ for six years as a senior trial attorney, handling some of the Antitrust Division’s highest-profile matters. Most prominently, he served a leading role in a two-month trial concerning competition in the credit card industry in which the DOJ prevailed. In addition, Mr. Hamer served on the trial teams of some of the Antitrust Division’s most significant merger challenges.
“Global antitrust compliance is becoming more complex, and coordinated investigations among the world’s competition authorities are increasingly common,” said Samantha Mobley, Chair of Baker & McKenzie’s Global Antitrust and Competition Practice. “Our global antitrust practice has a proven record of achieving worldwide results for our clients, and Mark’s extensive trial experience will further elevate the level of international one-stop shop service we provide.”
Prior to joining the DOJ, Mr. Hamer was a partner in the Antitrust Litigation group at DLA Piper, where he handled complex multi-district antitrust class actions, as well as civil and criminal antitrust enforcement actions and investigations.
Full content: BakerMckenzie
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Confusion Reigns In AI Policy In US and Europe
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas